(TNND) — Health Secretary Robert F. Kennedy Jr.'s decision to terminate nearly $500 million in government funding for mRNA vaccine development has alarmed public health experts. “This is a deeply ...

Despite Sanofi CEO Paul Hudson’s confidence in vaccines, the French pharma has cut at least one mRNA flu shot program.

Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, calling the vaccine technology "ineffective" and claiming it poses more risks ...

Two and a half years after Sanofi unveiled to investors a revamped strategy to create an mRNA seasonal flu vaccine, Fierce Biotech has learned that the French pharma has put this pipeline on ice.

Global mRNA Synthesis and Manufacturing Market OverviewThe global mRNA synthesis and manufacturing market is projected to grow at a compound annual growth rate of approximately 6% during the forecast ...

French drug company Sanofi announced it's discontinuing research and development for its next-generation mRNA flu vaccine.

HHS Secretary Robert F. Kennedy Jr.'s decision to cancel $500 million in funding and wind down development of mRNA vaccines is a disastrous one -- especially with the looming threat of an H5N1 avian ...

Add Yahoo as a preferred source to see more of our stories on Google. Many New Yorkers planning to use a vaccine to protect themselves and their children from COVID-19 in 2025 now face an increasingly ...

The U.S. Department of Health and Human Services is canceling contracts and pulling funding for the development of mRNA vaccines for respiratory illnesses such as COVID-19 and the flu. The decision ...

Please provide your email address to receive an email when new articles are posted on . HHS has canceled almost $500 million in funding for mRNA vaccine projects, citing safety and efficacy concerns.

Health and Human Services Secretary Robert F. Kennedy Jr.’s decision to terminate nearly $500 million in government funding for mRNA vaccine development has alarmed public health experts. “This is a ...